BPC-157 + TB-500 - Image 1
Click to enlarge
TB-500
TB-500 Price range: $49.99 through $89.99
Back to products
NAD+ (500mg)
NAD+ (500mg) $139.99

BPC-157 + TB-500

Price range: $89.99 through $159.99

BPC-157 + TB-500 is a research-grade blend combining two complementary tissue signaling peptides: BPC-157, a 15-amino-acid gastric-derived peptide, and TB-500, the active fragment of Thymosin Beta-4. In research settings, this combination is studied for its dual-pathway interactions across angiogenesis signaling, actin biology, cellular migration dynamics, and tissue repair mechanisms.

BioRhex supplies BPC-157 + TB-500 (20mg) as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.

  • In stock
  • COA-verified
  • ≥99% purity.
  • USA manufactured.
  • In stock
  • COA-verified
  • ≥99% purity.
  • USA manufactured.
  • COA-verified
  • In stock
  • ≥99% purity.
  • USA manufactured.

What Is BPC-157 + TB-500?

BPC-157 + TB-500 is a research-grade blend combining two complementary tissue signaling peptides: BPC-157, a 15-amino-acid gastric-derived peptide, and TB-500, the active fragment of Thymosin Beta-4. In research settings, this combination is studied for its dual-pathway interactions across angiogenesis signaling, actin biology, cellular migration dynamics, and tissue repair mechanisms.

BioRhex supplies BPC-157 + TB-500 (20mg) as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.

Compound Overview

This research blend combines two tissue signaling peptides studied across complementary repair pathway models. In vitro and preclinical research examines how this combination may influence:

• Complementary angiogenesis pathway engagement via VEGF and actin-mediated endothelial signaling
• BPC-157 gastric mucosal and tissue repair pathway activity
• TB-500 actin sequestration and cellular migration pathway signaling
• Combined inflammatory mediator modulation in tissue research models
• Multi-pathway ECM remodeling and wound repair biology

All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.

History of BPC-157 + TB-500

BPC-157 and TB-500 carry independent research histories that converge on tissue repair and angiogenesis pathway biology. BPC-157’s gastric-derived stability and VEGF-related signaling properties complement TB-500’s actin-based cellular migration mechanisms — engaging tissue repair research from two distinct molecular entry points.

Research interest in combining these two compounds stems from their mechanistically distinct but functionally complementary tissue biology interactions.

This blend is used in research settings to investigate multi-pathway tissue biology signaling dynamics not modeled by either compound alone.

Molecular Structure

BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-NH₂

Research Findings

Published and preclinical research on BPC-157 + TB-500 covers several areas of scientific investigation, including:

  • Dual angiogenesis pathway research: Studies examine complementary BPC-157 and TB-500 interactions with endothelial signaling and VEGF pathway dynamics.

  • Tissue remodeling dynamics: Research investigates combined effects on fibroblast activity and ECM reorganization signaling in tissue models.

  • Cellular migration modeling: Laboratory models explore TB-500 and BPC-157 effects on cell migration pathways in wound repair research systems.

  • Inflammatory signaling research: Studies evaluate combined modulation of inflammatory mediators in tissue repair experimental models.

All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.

References

FAQ

Q: What type of research is BPC-157 + TB-500 used for?

A: BPC-157 + TB-500 is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.

A: All BioRhex compounds, including BPC-157 + TB-500, are manufactured in a GMP-compliant facility located in the United States.

A: Every batch of BPC-157 + TB-500 undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.

A: No. BPC-157 + TB-500 is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.

A: Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.

Research Use Only

All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. BPC-157 + TB-500 is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.

RELATED PRODUCTS

AOD9604 (5mg)

,
$55.99
AOD9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH 177-191), with an additional tyrosine residue at the N-terminus. In research settings, AOD9604 is examined for its interactions with adipocyte signaling pathways and lipolytic mechanisms — studied independently of the growth-promoting effects associated with full-length GH. BioRhex supplies AOD9604 as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Add to cart
Quick view

BPC-157

,
Price range: $49.99 through $84.99
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a partial sequence of a naturally occurring gastric protection protein found in human gastric juice. In research settings, BPC-157 is examined for its interactions with angiogenic pathways, cellular repair signaling, and inflammatory mediator modulation in laboratory models. BioRhex supplies BPC-157 (5mg) as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Select options This product has multiple variants. The options may be chosen on the product page
Quick view

BPC-157 + TB-500

,
Price range: $89.99 through $159.99
BPC-157 + TB-500 is a research-grade blend combining two complementary tissue signaling peptides: BPC-157, a 15-amino-acid gastric-derived peptide, and TB-500, the active fragment of Thymosin Beta-4. In research settings, this combination is studied for its dual-pathway interactions across angiogenesis signaling, actin biology, cellular migration dynamics, and tissue repair mechanisms. BioRhex supplies BPC-157 + TB-500 (20mg) as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Select options This product has multiple variants. The options may be chosen on the product page
Quick view

CJC (no DAC) + Ipamorelin (10mg)

,
$84.99
CJC (no DAC) + Ipamorelin is a research-grade blend combining two complementary GH axis peptides. CJC-1295 without Drug Affinity Complex is a GHRH analogue engaging the hypothalamic-pituitary axis at the GHRH receptor level. Ipamorelin is a selective GHSR-1a agonist engaging the ghrelin receptor pathway. In research settings, this combination is studied for its dual-mechanism GH axis engagement and associated downstream signaling. BioRhex supplies CJC (no DAC) + Ipamorelin as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Add to cart
Quick view

Epitalon (50mg)

,
$179.99
Epitalon (Epithalon) is a synthetic tetrapeptide analogue of Epithalamin, a naturally occurring peptide isolated from bovine pineal gland tissue. In research settings, Epitalon is studied for its interactions with telomerase enzyme activity, telomere length regulation, and cellular aging pathway models. BioRhex supplies Epitalon as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Add to cart
Quick view